GB1313781A - 4,4-diarylpiperidines - Google Patents

4,4-diarylpiperidines

Info

Publication number
GB1313781A
GB1313781A GB3468870A GB3468870A GB1313781A GB 1313781 A GB1313781 A GB 1313781A GB 3468870 A GB3468870 A GB 3468870A GB 3468870 A GB3468870 A GB 3468870A GB 1313781 A GB1313781 A GB 1313781A
Authority
GB
United Kingdom
Prior art keywords
alkyl
july
nervous system
central nervous
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3468870A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemische Fabrik Promonta GmbH
Original Assignee
Chemische Fabrik Promonta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemische Fabrik Promonta GmbH filed Critical Chemische Fabrik Promonta GmbH
Publication of GB1313781A publication Critical patent/GB1313781A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1313781 Central nervous system stimulants CHEMISCHE FABRIK PROMONTA GmbH 17 July 1970 [17 July 1969] 34688/70 Heading A5B [Also in Division C2] Pharmaceutical compositions having central nervous system stimulant properties comprise a compound I in which R is H, 1-6C alkyl or an aralkyl, hydroxyalkyl, oxoalkyl, alkoxyalkyl, aryloxyalkyl or aryloxoalkyl group having 1-3C in the alkyl chain and R<SP>1</SP> is H or 1-4C alkyl or a salt thereof together with a suitable carrier. In the case of the known compounds I, viz where R is methyl or sec-butyl and R<SP>1</SP> is H, the carrier is not water or a common organic solvent.
GB3468870A 1969-07-17 1970-07-17 4,4-diarylpiperidines Expired GB1313781A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691936452 DE1936452C3 (en) 1969-07-17 1969-07-17 Process for the preparation of 4,4-diphenylpiperidines

Publications (1)

Publication Number Publication Date
GB1313781A true GB1313781A (en) 1973-04-18

Family

ID=5740133

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3468870A Expired GB1313781A (en) 1969-07-17 1970-07-17 4,4-diarylpiperidines

Country Status (10)

Country Link
JP (1) JPS5037670B1 (en)
AT (1) AT315176B (en)
BE (1) BE820593Q (en)
CH (2) CH550167A (en)
DE (1) DE1936452C3 (en)
ES (1) ES381966A1 (en)
FR (1) FR2059525B1 (en)
GB (1) GB1313781A (en)
HK (1) HK23078A (en)
NL (1) NL162070C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046156A3 (en) * 2000-12-06 2003-04-03 Sepracor Inc 4,4-disubstituted piperidines, and methods of use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6167770U (en) * 1984-10-12 1986-05-09
HN1999000149A (en) * 1998-09-09 2000-01-12 Pfizer Prod Inc DERIVATIVES OF 4,4-BIARILPIPERIDINA

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046156A3 (en) * 2000-12-06 2003-04-03 Sepracor Inc 4,4-disubstituted piperidines, and methods of use thereof

Also Published As

Publication number Publication date
FR2059525A1 (en) 1971-06-04
DE1936452B2 (en) 1974-11-07
NL162070B (en) 1979-11-15
NL7010655A (en) 1971-01-19
DE1936452C3 (en) 1975-06-19
DE1936452A1 (en) 1971-02-04
FR2059525B1 (en) 1974-03-22
CH550167A (en) 1974-06-14
CH554860A (en) 1974-10-15
HK23078A (en) 1978-05-12
BE820593Q (en) 1975-02-03
NL162070C (en) 1980-04-15
JPS5037670B1 (en) 1975-12-04
AT315176B (en) 1974-05-10
ES381966A1 (en) 1973-06-01

Similar Documents

Publication Publication Date Title
ES414279A1 (en) Benzodiazepine derivatives
NL179378C (en) PROCESS FOR THE PREPARATION OF FLUORALKOXYPHENYL SUBSTITUTED HETEROCYCLIC COMPOUNDS, OF A PLANT GROWTH INHIBITOR MIX, AND USE AS PLANT GROWTH REGULATORS.
GB1185238A (en) Use of 2-(2&#39;-Hydroxyphenyl)-Oxazole as a Disinfectant
GB1147379A (en) 4-alkyl-dialkoxy-ª‡-methylphenethylamines and pharmacologically acceptable salts
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1301973A (en)
GB1154744A (en) Disubstituted Aminoethanols
ES8202020A1 (en) Cephalosporin compounds and antibacterial drugs containing the same
GB1313781A (en) 4,4-diarylpiperidines
GB1354571A (en) Amides and their use as insecticides
GB1434174A (en) 7-trifluoromethylsulphinylacetamido cephalosporins
FI915245A0 (en) 7-ACYL-3- (SUBSTITUERADKARBAMOYLOXI) CEFEMFOERENINGAR SAMT FOERFARANDE FOER FRAMSTAELLNING AV DESSA.
GB1346710A (en) Antibacterial compositions
GB1331372A (en) Cyclic alpha-ketoamide derivatives
GB1274809A (en) Evomonoside derivatives
ES339432A1 (en) Novel halo-substituted tetrahydro-quinazolines
ES8401065A1 (en) Amino-2,1,3-benzothiadiazol and benzoxadiazol derivatives,preparation thereof and drugs containing them
GB1369294A (en) Purine-ribofuranoside-2,5,-cyclophosphates
GB1050554A (en)
GB1269776A (en) Epoxides and halohydrins and conversion thereof to alkanolamine derivatives
GB1136918A (en) Propanolamine derivatives
GB1338459A (en) Flavanone derivatives and process for inhibiting growth of microorganisms using such compounds
GB1439838A (en) Process for the preparation of diphenylamine and substituted derivatives thereof
GB1263677A (en) Process for the preparation of quinoxaline-di-n-oxide-aldehyde
GB1314293A (en) Prostaglandins and the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed
PLE Entries relating assignments, transmissions, licences in the register of patents
PCNP Patent ceased through non-payment of renewal fee